NASDAQ: CNTB
Connect Biopharma Holdings Ltd Stock Ownership - Who owns Connect Biopharma Holdings?

Insider buying vs selling

Have Connect Biopharma Holdings Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James HuangDirector2026-05-29150,000$2.48
$371.55kBuy
James HuangDirector2026-03-311,160,000$3.45
$4.00MBuy

1 of 1

CNTB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTB insiders and whales buy or sell their stock.

CNTB Shareholders

What type of owners hold Connect Biopharma Holdings Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Huang21.14%13,310,000$28.22MInsider
Ikarian Capital LLC8.56%5,388,486$11.42MInstitution
Boothbay Fund Management LLC1.96%1,234,582$2.62MInstitution
683 Capital Management LLC1.43%900,000$1.91MInstitution
Perceptive Advisors LLC1.26%792,696$1.68MInstitution
Adar1 Capital Management LLC1.18%742,400$1.57MInstitution
Richmond Brothers Inc0.76%476,584$1.01MInstitution
Millennium Management LLC0.75%474,601$1.01MInstitution
Bml Capital Management LLC0.65%408,887$866.84kInstitution
Knott David M Jr0.62%387,835$822.21kInstitution

1 of 3

CNTB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTB20.25%22.06%Net BuyingNet Buying
ADCT60.58%39.42%Net SellingNet Selling
GNLX20.72%6.26%Net SellingNet Selling
TLSA2.60%37.06%
GUTS45.39%18.43%Net BuyingNet Buying

Connect Biopharma Holdings Stock Ownership FAQ

Who owns Connect Biopharma Holdings?

Connect Biopharma Holdings (NASDAQ: CNTB) is owned by 20.25% institutional shareholders, 22.06% Connect Biopharma Holdings insiders, and 57.69% retail investors. James Huang is the largest individual Connect Biopharma Holdings shareholder, owning 13.31M shares representing 21.14% of the company. James Huang's Connect Biopharma Holdings shares are currently valued at $28.22M.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.